retatrutide 10MG

Retatrutide – Research Peptide

Product Summary:

Retatrutide is a novel investigational peptide designed as a triple receptor agonist, targeting the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This multi-agonist profile has made Retatrutide the focus of extensive preclinical and clinical research exploring its effects on metabolic regulation, glucose control, and body weight management.

In laboratory studies, Retatrutide has demonstrated potent activity in modulating insulin secretion, improving energy expenditure, and influencing lipid metabolism. Its unique receptor profile distinguishes it from single- or dual-agonist peptides, such as Semaglutide or Tirzepatide, providing a broader metabolic response in experimental settings.

Molecular Details

• Sequence: Proprietary

• Molecular Formula: C₂₂₅H₃₄₁N₅₅O₆₈

• Molecular Weight: ~5100 Da

• Purity: ≥ 98% (HPLC Verified)

• Form: Lyophilized powder

• Storage: Store at −20 °C, protected from light and moisture

⚠️

Important Warning & Disclaimer

• This product is NOT approved for human or veterinary use.

• Not for human consumption, injection, or diagnostic use.

• Use only in controlled research environments by qualified professionals.

• Handle with appropriate laboratory safety precautions, including use of gloves, protective eyewear, and lab coats.

• Any resale, marketing, or application suggesting human therapeutic or cosmetic use may violate UK MHRA regulations.